SCHEMBL19735520

SCHEMBL19735520

c1ccc(N(c2ccc(C3(c4ccccc4)c4ccccc4C4(c5ccccc5)c5ccccc5-c5cccc3c54)cc2)c2ccc3c(c2)sc2ccccc23)cc1

nearest known ligand 0.34

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
KDM4E B2RXH2 1/20 0.34
MEN1 O00255 1/20 0.34
LMNA P02545 1/20 0.34
OPRK1 P41145 1/20 0.34
KMT2A Q03164 1/20 0.34
ALDH1A1 P00352 2/20 0.33
HPGD P15428 1/20 0.33
RAB9A P51151 1/20 0.33
GPR3 P46089 1/20 0.31
POLB P06746 1/20 0.30
TDP1 Q9NUW8 1/20 0.30
L3MBTL1 Q9Y468 1/20 0.30
ESR1 P03372 1/20 0.30
ESR2 Q92731 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19735533 0.93 MEN1 (0.34) MAPTSMN1; SMN2KDM4EMEN1LMNA
SCHEMBL17805040 0.93 MAPT (0.39) MAPTSMN1; SMN2KDM4EMEN1LMNA
SCHEMBL19735450 0.90 MAPT (0.31) MAPTSMN1; SMN2KDM4EMEN1LMNA
SCHEMBL21559101 0.90 MAPT (0.34) MAPTSMN1; SMN2KDM4EMEN1LMNA
SCHEMBL21037305 0.90 MAPT (0.34) MAPTSMN1; SMN2KDM4EMEN1LMNA
SCHEMBL17805008 0.90 MAPT (0.36) MAPTSMN1; SMN2KDM4EMEN1LMNA
SCHEMBL23353772 0.89 MAPT (0.35) MAPTSMN1; SMN2KDM4EMEN1LMNA
SCHEMBL21239187 0.89 MAPT (0.38) MAPTSMN1; SMN2KDM4EMEN1LMNA
SCHEMBL24883155 0.89 MAPT (0.35) MAPTSMN1; SMN2KDM4EMEN1LMNA
SCHEMBL23096430 0.88 MEN1 (0.39) MAPTSMN1; SMN2KDM4EMEN1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3369719-B1 SPIRO-TYPE COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEMICAL LTD (KR) 2020-02-26 EP disclosed
US-9960357-B2 Spiro-type compound and organic light emitting element comprising same LG CHEM, LTD. (KR) 2018-05-01 US disclosed
US-9960357-B2 Spiro-type compound and organic light emitting element comprising same LG CHEM, LTD. (KR) 2018-05-01 US disclosed
US-20170365787-A1 SPIRO-TYPE COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2017-12-21 US disclosed
US-20170365787-A1 SPIRO-TYPE COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2017-12-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170365787-A1 SPIRO-TYPE COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME CRY1, NR2E3, LEF1 MAPT 1516/4885SMN1; SMN2 3563/4885KDM4E 3359/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.